NEW YORK (GenomeWeb News) – Genetic Technologies this week announced a settlement and licensing agreement with Promega. Under the terms of the deal, GTG granted Promega "broad rights" to GTG's Intron Sequence Analysis and Genomic Mapping patents. Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.